« Home « Chủ đề hoạt chất dược phẩm

Chủ đề : hoạt chất dược phẩm


Có 40+ tài liệu thuộc chủ đề "hoạt chất dược phẩm"

Pharmaceutical Substances Syntheses, Patents, Applications - Part 20

tailieu.vn

RN MF: C3,H4,N20, MW: 626.75 EINECS: 258-710-3. ointment 3 % Trade Name(s):. SOlBC07 Use: anti-inflammatory RN MF: C,,H,,N20, MW: 282.30 EINECS: 243-569-2. LD,: 380 mglkg (M, i.v. 1105 mglkg (M, p.0.);. RN MF: C,,H,,N,NaO, MW: 304.28 EINECS: 245-528-4. 3 % Trade Name(s):. 395 mglkg (M, i.v. Trade Name(s):. Use: cytoprotective agent (for treatment of gastric ulcer), chymotrypsin inhibitor RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 21

tailieu.vn

Trade Name(s):. Use: pancreas function diagnostic RN MF: C23H20N20, MW: 404.42 EINECS: 253-349-8. 333 rng Trade Name(s):. RN MF: unspecified MW: unspecified CN: benzalkonium chloride. RN MF: CI,H140, MW: 266.30 EINECS LD. 5.12.1961. 100 mg Trade Name(s):. RN MF: C,6H,,N204S . Formulation(s): gel 0.1 gI100 g Trade Name(s):. N O ~ A C O I Use: uricosuric agent RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 22

tailieu.vn

RN MF: C,,H,,N . LD,: 25 mg/kg (M, i.v. 460 mglkg (M, p.0.);. 33 mg/kg (M, i.v. 440 mglkg (M, p.0.);. 43.5 mg/kg (R, i.v. 324 mglkg (M, i.v.j. 1360 mglkg (M, p.0.);. 1230 m g k g (R, p.0.) CN: benzenemethanol. >22440 mglkg (dog, p.0.) CN: benzoic acid phenylmethyl ester. 150 mg/kg (M, s.c.). 329 mglkg (M, i.v. 6916...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 23

tailieu.vn

Use: diaminooxydase inhibitor RN MF: C8H12N2 MW: 136.20 EINECS: 227-086-4. RN MF: C8H12N2. RN MF: C6H707 . 1 1.20-dione (I) methane 16-pregnene-11.20-dime. 3a-acetoxy-16p-methyl- acetic 3a.20-diacetoxy-16p- hydroxide. 16j-methyI-3m.l7a,21- 17m.21 -dihydroxy-168- trihydroxypregnone-11.20- rncthylpregnane-3.11.2D-. pregnane-3.1 1.20-trione 2 1 -ocetate. 3a-acetoxy-16a.17a-epoxy- 58-pregnane-11.20-dione 21 -ethylene acetal (XVI). 3a-acetoxy-20.20- ethylenedioxy-l6a,17o- apoxy-5~-pregnon-l18-ol ( X W. 11.9.1962. 11.8.1972).

Pharmaceutical Substances Syntheses, Patents, Applications - Part 24

tailieu.vn

RN MF: C2,H,,FO7 MW: 504.60 EINECS LDso: >5 glkg (M, p.0.);. Use: glucocorticoid RN MF: C3,H4,F0, MW: 560.70 EINECS: 253-820-8. rectal ointment 0.05 % Trade Name(s):. 700 mglkg (M, i.p.). RN MF: C2,H2,FNa20,P MW: 5 16.41 EINECS LD. 1607 mglkg (M, p.0.);. 14.12.1972. 6.6 mg/100 g Trade Name(s):. Use: glucocorticoid RN MF: C,7H3,F06 MW: 476.59 EINECS: 218-439-3. 0.1 mg Trade...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 25

tailieu.vn

Use: non-steroidal antiandrogen, antineoplastic, anti(pr0state)cancer RN MF: CI8Hl4F4N2O4S MW: 430.38. RN MF: C1,H,,F4N,O4S MW: 430.38 S-enantiomer. RN MF: C18H14F4N204S MW: 430.38. RN MF: C,yH,oN,02 .2HCl MW: 391.38 EINECS LD. RN MF: C3,HS3N309. RN MF: C,,H,,F,O, MW: 292.33. RN MF: C,,H,,N, MW: 310.40 EINECS LD. RN MF: CZ2H,,N2, HC1 MW: 346.86 sulfate. ATC: N06AB Use: antidepressant RN MF: ClyHz3N3 MW: 293.41....

Pharmaceutical Substances Syntheses, Patents, Applications - Part 26

tailieu.vn

RN MF: C2,HZ2N8 MW: 398.47 LD. RN MF: C2,H2,N8 . 2.10.1978).. RN MF: C38H42Nn06S2 MW: 770.94 EINECS LD. RN MF: C,,H3,NO4 MW: 325.45. RN MF: C,,H3,N04 . 9.10.1976).. RN MF: C18H,,NOs MW: 461.56. RN MF: CZ8H3,NO5. 31.4 mglkg (M, i.v.);41 16 rnglkg (M, p.0.);. Use: antineoplastic (peptide antibiotic) RN MF: C5,H84N1702,S3 MW: 141 5.57 EINECS: 234-356-5. Use: antibiotic RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 27

tailieu.vn

antibacterial RN MF: C,,H1,BrN,O, MW: 339.19 EINECS CN: 5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]-2,4-pyrimidinediamine hydrochloride. RN MF: C13HlsBrN402, HCI MW: 375.65. 200 mg Trade Name(s):. ATC: N05BA08 Use: tranquilizer RN MF: C,,HloBrN,O M W 3 16.16 EINECS LD,: 879 mg/kg (M, p.0.);. 3 mg, 6 mg Trade Name(s):. RN MF: C,,H,,BrNO . 25 mg Trade Name(s):. Use: anti-inflammatory, antineoplastic RN MF: unspecified MW: unspecified EINECS:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 28

tailieu.vn

Use: prolactin inhibitor RN MF: C,,H,,,BrN,O, MW: 654.61 EINECS: 247-128-5. LD,: >800 mglkg (M, p.0.);. RN MF: C3,H,oBrN,0. 2502 mglkg (M, p.0.);. 2.5 mg (as mesylate) Trade Name(sJ. Use: anti-emetic, gastric therapeutic RN MF: C,,H,,BrN30, MW: 344.25 EINECS: 223-842-2. drops 13.3 mg Trade Narne(s):. Use: antipsychotic, neuroleptic RN MF: C,,H,,BrFNO, MW: 420.32 EINECS: 233-943-3. 174 mglkg (M, p.0.);. RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 29

tailieu.vn

27.4.1970. 28.4.1969).. 28.4.1969. R03BA02 Use: topical glucocorticoid, antiasthmatic RN MF: C,,H3,O6 MW: 430.54 EINECS: 257-139-7. 4750 mglkg (M, p.0.);. >3200 mglkg (R, p.0.). 30.12.1975. 14.5.1973. 19.5.1973. 14.5.1973).. RN MF: C,,H2,N MW: 293.45 EINECS LD. 165 mglkg (R, p.0.). RN MF: CZIH2,N . RN MF: C,,H,,N4 MW: 240.31 LD. 1820 mglkg (M, p.0.);. 3570 mglkg (R, i.p. 14.9.1970).. Use: beta blocking...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 30

tailieu.vn

Use: antihypertensive, vasodilator RN MF: C,,H2,I,NO2 MW. 29.12.1967. ATC: NOlBBOl Use: local anesthetic RN MF: CIRHZ8N2O MW. RN MF: C,,H,,N,O . 0.75 % Trade Name(s):. Use: beta blocking agent RN MF: CI4H,,CINO2 MW: 271.79. 15.3 mglkg (R, i.v. 518 mglkg (R, p.0.);. Use: analgesic RN MF: C2,H4,NO4 MW: 467.65 EINECS LD. RN MF: C2,H4,N04 . 5.12.1984. synthetic nonapeptidc agonist analog...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 31

tailieu.vn

RN MF: C24H31N30S . Butenafine Use: antifungal for topical use RN MF: C2,H2,N MW: 317.48. RN MF: CZ3Hz7N . 3 1.10.1986. ATC: SOlFA Use: antispasmodic RN MF: C,,H2,N02 MW: 263.38 EINECS: 237-817-9. RN MF: C,,H2,N02 . Use: local anesthetic RN MF: C,,H2,N202 MW: 236.32. Trade Name(s):. Use: non-steroidal anti-inflammatory RN MF: Cl4HzOO2 MW: 220.3 1 EINECS: 259-849-2. RN MF: C,,H,,NaO,...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 32

tailieu.vn

Use: doparnine D, receptor antagonist, prolactin inhibitor for prevention or suppression of puerperal lactation RN MF: C,,H,,N,O, MW: 451.62. RN MF: unspecified MW: unspecified LD50: >2 glkg (R, i.p. Use: antihypertensive, vasodilator RN MF: Cl,H,,N,O, MW: 283.33. RN MF: C,,H,,N,O, MW: 267.29 EINECS LD. Use: circulatory analeptic RN MF: C,,H,,N,O, MW: 357.41. RN MF: C,,H,,N,O, MW: 357.41 [R-(R*,S*)]-monohydrochloride. RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 33

tailieu.vn

8.12.1977. 8.12.1976).. 12.1 1.1974. Use: hemostatic (capillary protective) RN MF: C,2H,,Ca0,0S2 MW: 418.41 EINECS: 243-531-5. Use: cerebral activator RN MF: C20H,,CaN20,0 MW: 504.59. RN MF: C,,,H,,NOS MW: 233.26. RN MF: C,H,,NNa05 MW: 241.22 EINECS . 29.1.1975. 24.12.1975. 19.2.1975).. 30.8.1977. 12.5.1972. 24.2.1977).. 12.9.1967. Use: sedative, tranquilizer RN MF: C,,H,,ClN,O, MW: 371.82 EINECS: 252-866-6. 18.2.1975. 22.12.1975. 9.12.1960. RN MF: C2,H22N40, MW: 398.42....

Pharmaceutical Substances Syntheses, Patents, Applications - Part 34

tailieu.vn

12.5.1964).. 28.12.1976. Roche S.A.R.L.)-comb.. 1.12.1993. 5.12.1995. 19.12.1995. Trade Name(s):. RN MF: C2,H,N,,08 MW: 668.72 LD,: 238 mglkg (M, i.v.). RN MF: H2S0. 20.1.1982).. 12.1.1982. 29.12.1980. 16.8.1983. 17.5.1983. 24.8.1982. 25.10.1983. 16.1982. 15.12.1978. 30.6.1983).. 6.25 mg, 12.5 mg, 25 mg, 50 mg Trade Namefs):. D: Capozide (Bristol-Myers Squibb. Lopril (Bristol-Myers Squibb. Capozide (Bristol-Myers Squibb. RN MF: C5H,CaN,0, MW: 214.19 EINECS CN: N-(aminocarbony1)-L-aspartic...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 35

tailieu.vn

Trade Name(s):. Use: antibiotic RN MF: C17H18N206S MW: 378.41 EINECS LD. RN MF: CI7H,,N2Na20,S MW: 422.37 EINECS LD. 10 g k g (R, p.0.) monopotassium saIt. RN MF: Cl7Hl7KN2O6s MW: 416.50 EINECS: 241-269-6. 1.10.1971).. 382 mg Trade Numeis):. Use: peptic ulcer therapeutic RN MF: C,,HSoO, MW: 570.77 EINECS: 227-174-2. RN MF: C,,H,8Na,0, MW: 6 14.73 EINECS LD. 198 mglkg (M,...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 36

tailieu.vn

Use: antibiotic RN MF: C23H22N206S MW: 454.50 EINECS LD. 3924 mglkg (M, p.0.). 10.12.1974. Trade Name(s):. ATC: NO5AK Use: neuruleptic RN MF: C2,H,,N3O2S MW: 425.60 EINECS: 220-072-9. RN MF: C2,H3,N302S 2C4H404 MW: 657.74 EINECS LD. 162 mglkg (R, p.0.). 25 mg, 400 mg Trade Name(s):. Carbenicillin Indanyl Sodium) Use: antibiotic RN MF: C2,H,,N20,S MW: 494.57. RN MF: C26H,,N,Na06S MW: 5...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 37

tailieu.vn

Use: local anesthetic RN MF: C,,H2,N20,S MW: 284.38. RN MF: C,,H,,N,O,S . 17.12.1974. Use: antibacterial (monobactam antibiotic) RN MF: C,,H,,N,O,,S, MW: 466.41. RN MF: C,,HI2N,Na2Ol,S, MW: 510.37. 30.4.1982;. 31.5.1982;. 9.12.1982).. Use: non-selective PI-adrenoceptor blocker with vasodilating activity RN MF: C,H,,N,O, MW: 406.48. 6.25 mg, 12.5 mg, 25 mg, 50 mg. RN MF: C7H,NNa04S MW: 223.18. ATC: J01DA34 Use: antibiotic RN...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 38

tailieu.vn

ATC: JOlDA Use: antibiotic RN MF: C,,HI,N306S MW: 405.43 EINECS LD. CN: [6R-(6a,7~(R*))]-3-[(acetyloxy)methyl]-7-[(amin~phenylacetyl)amino]-8-oxo-5-thia-l- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. RN MF: C,,H,,N306S . 10.1.1963. 23.8.1968).. 14.2.1978. 14.5.1975).. ATC: JOlDA02 Use: antibiotic RN: 50-59-9 MF: Cl,H,,N3O4S2 MW: 415.49 EINECS LD. CN: (6R-trans)-l-[[2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-l-azabicyclo[4.2.0]oct-2-en-3- yl]methyl]pyridinium hydroxide inner salt. 14.12.1963. 13.12.1963. ATC: JOlDA03 Use: antibiotic RN: 153-61-7 MF: C,6H,,N20,S2 MW: 396.44 EINECS LD. CN: (6R-trans)-3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-l-azabicyclo[4.2.O]oct-2-ene- 2-carboxylic acid. 23.1...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 39

tailieu.vn

RN MF: C25H28N607S3 M W : 620.73. RN MF: C,SH28N607S3 M W : 620.73. RN MF: C,,H,,N,07S2 MW: 453.46 LDso: 4420 m g k g (M, i.v. CN: [6R-[6a,7~(Z)]]-7-[[(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5- thia-l-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. RN MF: C1,Hl,N,07S2~ 3 H 2 0 MW: 507.50. 27.12.1983. 11.12.1984. RN MF: C,,H,,N,OSS3 MW: 51 1.57. [6R-[6a,7~(Z)l]-7-[[(2-amino-4-thiazolyl)(methoxyiminv)cetyl]amino]-3-[[(l-methyl-1H-tetrazol-5- yl)thiolmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. RN MF: C,,H,,N,0SS3 . 17.12.1975. 19.12.1974. Use: antibiotic RN...